Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Nihon Kohden Corporation ( (JP:6849) ) just unveiled an announcement.
Nihon Kohden has agreed to acquire a 90.3% stake in DOWELL Co., Ltd., a Sapporo-based developer of medical information systems for physicians and nurses, making it a consolidated subsidiary, while DOWELL’s founder Yoshihiro Shindo will retain a 9.7% stake and continue in management. The deal, backed by a shareholders agreement that includes put and call options on Mr. Shindo’s remaining shares, is aimed at combining both companies’ IT and digital health strengths to develop next-generation perioperative and data-integration solutions, improve operational efficiency in medical practice, and support Nihon Kohden’s BEACON 2030 vision, with only a minor impact expected on near-term financial results.
The most recent analyst rating on (JP:6849) stock is a Buy with a Yen1814.00 price target. To see the full list of analyst forecasts on Nihon Kohden Corporation stock, see the JP:6849 Stock Forecast page.
More about Nihon Kohden Corporation
Nihon Kohden Corporation is a Japan-based medical device and healthcare IT company listed on the Tokyo Stock Exchange Prime Market. It develops and sells patient monitoring systems, diagnostic equipment and IT and digital health solutions, with a strong presence in operating rooms and examination room support systems in the Japanese market. The company’s long-term strategy focuses on leveraging clinical data to build integration platforms and advanced algorithms that enhance the quality and efficiency of medical care.
Average Trading Volume: 586,272
Technical Sentiment Signal: Buy
Current Market Cap: Yen296.7B
See more insights into 6849 stock on TipRanks’ Stock Analysis page.